Clinically Relevant Genetic Testing – Delivered Direct to your Patients

Our targeted portfolio of self-collection tests is designed to support proactive, evidence-based healthcare. From bowel cancer screening and pharmacogenomic profiling to hypertension risk assessment and DPYD variant analysis for optimising cancer treatment safety, each test is grounded in current clinical guidelines and backed by accredited laboratory processes.

Empower your patients with access to high-quality diagnostic tools—streamlined for at-home collection, with results that integrate seamlessly into clinical decision-making.